We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.45% |
| 2 | Technology | 22.86% |
| 3 | Financials | 11.48% |
| 4 | Communication Services | 7.14% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CARL
3176
Carlsmed
CARL
$384M
| $32.4K | ﹤0.01% |
+3,577
| New | +$43.2K |
|
3177
INNOVATE Corp
VATE
$101M
| $32.3K | ﹤0.01% |
+5,691
| New | +$28.9K |
|
3178
Empire Petroleum
EP
$94.9M
| $32.1K | ﹤0.01% |
+10,837
| New | +$33.3K |
|
3179
Tilly's
TLYS
$142M
| $32K | ﹤0.01% |
+7,911
| New | +$16K |
|
3180
INVE Technologies, Inc. Common Stock
INVE
$57.2M
| $32K | ﹤0.01% |
+8,642
| New | +$29.1K |
|
|
NCSM
3181
DELISTED
NCS Multistage Holdings
NCSM
| $31.7K | ﹤0.01% |
+512
| New | +$24.2K |
|
3182
1-800-Flowers.com
FLWS
$160M
| $31.5K | ﹤0.01% |
+10,368
| New | +$38.8K |
|
3183
PepGen
PEPG
$168M
| $31.4K | ﹤0.01% |
+17,723
| New | +$99.6K |
|
3184
RCM Technologies
RCMT
$289M
| $31.3K | ﹤0.01% |
+1,635
| New | +$31.8K |
|
3185
Pyxis Oncology
PYXS
$194M
| $31K | ﹤0.01% |
+21,242
| New | +$32K |
|
3186
Full House Resorts
FLL
$52M
| $31K | ﹤0.01% |
+13,765
| New | +$33.1K |
|
|
EEX
3187
DELISTED
Emerald Holding
EEX
| $30.7K | ﹤0.01% |
+6,815
| New | +$31.4K |
|
3188
Beneficient
BENF
$21.1M
| $30.6K | ﹤0.01% |
+8,750
| New | +$37.9K |
|
3189
Knightscope
KSCP
$18.3M
| $30.6K | ﹤0.01% |
+7,340
| New | +$29.3K |
|
3190
Outset Medical
OM
$56.4M
| $30.3K | ﹤0.01% |
+7,902
| New | +$32.4K |
|
3191
Humacyte
HUMA
$144M
| $30.3K | ﹤0.01% |
+49,866
| New | +$51.8K |
|
3192
SkinHealth Systems
SKIN
$82M
| $30K | ﹤0.01% |
+33,734
| New | +$41.4K |
|
3193
FitLife Brands
FTLF
$87.3M
| $30K | ﹤0.01% |
+2,110
| New | +$31.6K |
|
3194
Digimarc Corp
DMRC
$131M
| $29.9K | ﹤0.01% |
+6,090
| New | +$33.8K |
|
|
NTHI
3195
NeOnc Technologies
NTHI
$97.9M
| $29.9K | ﹤0.01% |
+4,265
| New | +$38.8K |
|
3196
Aldeyra Therapeutics
ALDX
$74.2M
| $29.9K | ﹤0.01% |
+17,687
| New | +$77.5K |
|
3197
Northern Technologies International Corp
NTIC
$73.9M
| $29.8K | ﹤0.01% |
+3,622
| New | +$32K |
|
3198
Chegg
CHGG
$80.6M
| $29.8K | ﹤0.01% |
+40,241
| New | +$28.3K |
|
3199
EVI Industries
EVI
$247M
| $29.6K | ﹤0.01% |
+1,440
| New | +$32.3K |
|
3200
New Fortress Energy
NFE
$35.8M
| $29.6K | ﹤0.01% |
+1,002
| New | +$58.6K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, followed by Technology and Financials.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.